Chimeric Therapeutics

3:30 PM - 3:45 PM (PDT), Monday, June 13, 2022
Chimeric Therapeutics is a clinical stage cell therapy company focused in oncology. Our mission is to bring the promise of cell therapy to life for more patients with cancer by discovering, developing and commercializing cell therapies with the most curative potential for patients.
Ticker:
CHM
Exchange:
ASX
Company Type:
Publicly Traded Company
Company HQ State:
Not Provided
Company HQ Country:
Australia
Year Founded:
2020
Main Therapeutic Focus:
Lead Product in Development:
CHM 1101 - CLTX CAR T
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2